Print Handout

Unbiased information for educational purposes only. WoundReference does not produce, market, advertise, re-sell or distribute healthcare goods or services consumed by, or used on patients. For information about specific products, please contact the manufacturer directly.

Technology and Product Assessment:

REGRANEX (becaplermin) Gel, 0.01%, 15g tube

Product Type: Growth factor - recombinant

Other related brands

Smith & Nephew, Inc. | |

HCPCS : S0157 (Medicare DME co-payment per billable unit min / max: $0.00 / $0.00)

Overview
Patient Info

REGRANEX Gel is a recombinant platelet-derived growth factor (PDGF).
INTENDED USES: For use on diabetic neuropathic ulcers.
CLAIMED FEATURES: is the only FDA-approved recombinant platelet-derived growth factor (PDGF) therapy. REGRANEX (becaplermin) Gel, 0.01% contains becaplermin, a human platelet-derived growth factor that is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply. It is indicated as an adjunct to, and not a substitute for, good ulcer care practices.IMPORTANT SAFETY INFORMATION WARNING: INCREASED RATE OF MORTALITY SECONDARY TO MALIGNANCY - An increased rate of mortality secondary to malignancy was observed in patients treated with 3 or more tubes of REGRANEX (becaplermin) Gel, 0.01% in a postmarketing retrospective cohort study. REGRANEX Gel should only be used when the benefits can be expected to outweigh the risks. REGRANEX Gel should be used with caution in patients with known malignancy.
OPTIONS: Gel, 0.01%, 15g tube

Wound Reference does not produce, market, re-sell or distribute health care goods or services consumed by, or used on, patients.

Compare Features

Growth factors are substances that occur naturally in the body. They promote growth of new cells and healing of wounds. Studies show that treatment of diabetic foot ulcers with growth factors may improve the healing of ulcers, when compared with placebo or no growth factor. One example of growth factor that is produced in laboratory and made commercially available is becaplermin. Available as a topical gel, becaplermin is a human platelet-derived growth factor indicated for the treatment of lower extremity diabetic neuropathic ulcers, along with standard wound care.

Becaplermin topical gel can be purchased from pharmacies with a prescription from your provider.

Go to REGRANEX* (becaplermin) Gel 0.01%

REGRANEX (becaplermin) Gel, 0.01%, 15g tube

Other related brands:

No related products

* Wound Reference does not produce, market, re-sell or distribute health care goods or services consumed by, or used on, patients.
** We do not accept paid advertising to guarantee unbiased product information

Important Notice: The product information contained on this page, including the product images and additional product materials, was collected from various supplier sources. All product claims and specifications are those of the product suppliers. Every effort has been made to ensure the accuracy of the product information, however on occasion manufacturers may alter their products or packaging without notice. Wound Reference assumes no liability for inaccuracies or misstatements about products. The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Due to product changes, information listed in this document is subject to change without notice. We recommend that you always read labels, warnings and instructions for use before using a product. Content on this site is for reference purposes and is not intended to be a substitute for professional advice given by a physician or other licensed healthcare professional.

REGRANEX (becaplermin) Gel, 0.01%, 15g tube

Related Products (Compare Features )

Basic Navigation

Feature Navigation

Solutions

Individuals:

Institutions:

Special Features:

Newsletter Signup